Page 14 - Charity Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

It, they love it. what are you making this move? >> -- >> you rarely hear about a mega giant saying, we're gonna end a charity program. >> i know, it's tough. on to the ceo they're doing a big cost review, and according to the reporting, amazon says it wasn't going far enough. the money, this little percentage of each thing you buy those was to go to your favorite charity, was only disturbing a couple hundred bucks to each charity per person. that said, you know, my elementary school to my kids are going to, they took an assortment of money from this thing. and it says to me, both that these c...

The clear sense they need to make a change in something, we'll, chatgpt can not only write all those letters for you, it can personalize them to the senator in question. senator, whoever it is, i know that your constituents are particle interested in this, you voted this way in that way. this is not just a mimicry, a language mimicry machine, it's a knowledge mimicry machine. that can pick up the patterns and stuff that we know some past history about my life in your life. you know, we have those places in which ceos have been tricked into, you know, handing over information because somebody i...

We'll, chatgpt can not only write all those letters for you, it can personalize them to the senator in question. senator, whoever it is, i know that your constituents are particle interested in this, you voted this way in that way. this is not just a mimicry, a language mimicry machine, it's a knowledge mimicry machine. that can pick up the patterns and stuff that we know some past history about my life in your life. you know, we have those places in which ceos have been tricked into, you know, handing over information because somebody impersonate something about their life. this thing can do ...

 If you use AmazonSmile to help your favorite charity, you may want to start donating directly

This year, the Office of Inspector General ("OIG") and at least two federal courts have taken a clear stance against pharmaceutical manufacturers' attempts to offer cost-sharing subsidies...